Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306969 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Song Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Basic Medicine, General Hospital of Northern Theater Command, Shenyang, China. Hauptthemen laut MEDLINE: Docetaxel, Polyploidy, Ovarian Neoplasms, Kruppel-Like Factor 4. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key research and development guidance plan of Liaoning Province.
Abstract (Originalsprache)
Docetaxel (Doc) plays a crucial role in clinical antineoplastic practice. However, it is continuously documented that tumors frequently develop chemoresistance and relapse, which may be related to polyploid giant cancer cells (PGCCs). The aim of this study was investigate the formation mechanism and biological behavior of PGCCs induced by Doc. Ovarian cancer cells were treated with Doc, and then the effect of Doc on cellular viability was evaluated by MTT assay and microscopic imaging analysis. The biological properties of PGCCs were further evaluated by Hoechst 33342 staining, cell cycle and DNA content assay, DNA damage response (DDR) signaling detection, β-galactosidase staining, mitochondrial membrane potential detection, and reverse transcription-quantitative polymerase chain reaction. The results indicated that Doc reduced cellular viability; however, many cells were still alive, and were giant and polyploid. Doc increased the proportion of cells stayed in the G2/M phase and reduced the number of cells. In addition, the expression of γ-H2A.X was constantly increased after Doc treatment. PGCCs showed senescence-associated β-galactosidase activity and an increase in the monomeric form of JC-1. The mRNA level of octamer-binding transcription factor 4 ( OCT4) and krüppel-like factor 4 ( KLF4) was significantly increased in PGCCs. Taken together, our results suggest that Doc induces G2/M cell cycle arrest, inhibits the proliferation and activates persistent DDR signaling to promote the formation of PGCCs. Importantly, PGCCs exhibit a senescence phenotype and express stem cell markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Basic Medicine, General Hospital of Northern Theater Command, Shenyang, China.
ORCID-Profile: Huiying Yu
Förderung
- Key research and development guidance plan of Liaoning Province
Zitieren
APA
Zhao, S., Wang, L., Ouyang, M., Xing, S., Liu, S., Sun, L., & Yu, H. (2024). Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0306969
Vancouver
Zhao S, Wang L, Ouyang M, Xing S, Liu S, Sun L, et al. Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0306969
BibTeX
@article{Zhao2024,
author = {Zhao, Song and Wang, Lili and Ouyang, Mingyue and Xing, Sining and Liu, Shuo and Sun, Lingyan and Yu, Huiying},
title = {Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306969}
}
EUVIMED